Apeiron Investment Group Ltd.

CIK: 0001845711

Transaction Breakdown

Open Market Buys (P)14 (63.6%)

High conviction signal

Open Market Sales (S)3 (13.6%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)1 (4.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (3)

ENHA

Enhanced Group Inc.

Director10% Owner

ATAI

ATAI Life Sciences N.V.

10% Owner

BNOX

BIONOMICS LTD/ADR

10% Owner

Discretionary Trading P&L

Holdings

Transaction History (22 total)

ENHA
Enhanced Group Inc.
Sep 17, 2026
Purchase(P)
Indirect
6.1M shares at avg. $1.15$7.0M
ENHA
Enhanced Group Inc.
Sep 9, 2026
Purchase(P)
Indirect
99.3K shares at avg. $1.60$159K
ENHA
Enhanced Group Inc.
Sep 8, 2026
Purchase(P)
Indirect
59.3K shares at avg. $1.57$93K
ENHA
Enhanced Group Inc.
Sep 4, 2026
Purchase(P)
Indirect
21K shares at avg. $1.61$34K
ENHA
Enhanced Group Inc.
Sep 3, 2026
Purchase(P)
Indirect
25.4K shares at avg. $1.58$40K
ENHA
Enhanced Group Inc.
Sep 2, 2026
Purchase(P)
Indirect
107.7K shares at avg. $1.58$170K
ENHA
Enhanced Group Inc.
Aug 19, 2026
Purchase(P)
Indirect
1.6M shares at avg. $1.66$2.7M
ENHA
Enhanced Group Inc.
Aug 19, 2026
Purchase(P)
Indirect
55K shares at avg. $1.64$90K
ENHA
Enhanced Group Inc.
Aug 18, 2026
Purchase(P)
Indirect
93K shares at avg. $1.70$158K
ENHA
Enhanced Group Inc.
Aug 17, 2026
Purchase(P)
Indirect
200K shares at avg. $1.65$330K
ENHA
Enhanced Group Inc.
Aug 14, 2026
Award(A)
Indirect
2.1M shares-
ENHA
Enhanced Group Inc.
Aug 14, 2026
Purchase(P)
Indirect
150K shares at avg. $1.97$296K
ENHA
Enhanced Group Inc.
Jul 22, 2026
Award(A)
Indirect
3M shares-
ENHA
Enhanced Group Inc.
May 7, 2026
Award(A)
Indirect
29.7M shares-
ENHA
Enhanced Group Inc.
May 7, 2026
Award(A)
Indirect
258.8M shares-
ATAI
ATAI Life Sciences N.V.
Sep 30, 2025
Conversion(C)
Indirect
2.4M shares-
ATAI
ATAI Life Sciences N.V.
Aug 14, 2025
Purchase(P)
Indirect
8.7M shares at avg. $2.19$19.0M
ATAI
ATAI Life Sciences N.V.
Mar 24, 2025
Purchase(P)
Indirect
1.8M shares at avg. $1.40$2.5M
ATAI
ATAI Life Sciences N.V.
Feb 14, 2025
Purchase(P)
Indirect
10.8M shares at avg. $2.10$22.8M
BNOX
BIONOMICS LTD/ADR
Oct 4, 2024
Sale(S)
Indirect
557 shares at avg. $0.28$155.96
BNOX
BIONOMICS LTD/ADR
Oct 3, 2024
Sale(S)
Indirect
180.7K shares at avg. $0.29$52K
BNOX
BIONOMICS LTD/ADR
Oct 2, 2024
Sale(S)
Indirect
90.8K shares at avg. $0.33$30K

		Type	Shares	Price		Ownership
Sep 17, 2026	ENHA Enhanced Group Inc.	Purchase(P)	6,080,047	$1.15	$6,992,054	Indirect
Sep 9, 2026	ENHA Enhanced Group Inc.	Purchase(P)	99,342	$1.60	$159,374	Indirect
Sep 8, 2026	ENHA Enhanced Group Inc.	Purchase(P)	59,337	$1.57	$93,076	Indirect
Sep 4, 2026	ENHA Enhanced Group Inc.	Purchase(P)	21,034	$1.61	$33,898	Indirect
Sep 3, 2026	ENHA Enhanced Group Inc.	Purchase(P)	25,414	$1.58	$40,152	Indirect
Sep 2, 2026	ENHA Enhanced Group Inc.	Purchase(P)	107,693	$1.58	$169,627	Indirect
Aug 19, 2026	ENHA Enhanced Group Inc.	Purchase(P)	1,619,316	$1.66	$2,688,065	Indirect
Aug 19, 2026	ENHA Enhanced Group Inc.	Purchase(P)	55,000	$1.64	$90,382	Indirect
Aug 18, 2026	ENHA Enhanced Group Inc.	Purchase(P)	93,000	$1.70	$158,212	Indirect
Aug 17, 2026	ENHA Enhanced Group Inc.	Purchase(P)	200,000	$1.65	$330,420	Indirect
Aug 14, 2026	ENHA Enhanced Group Inc.	Award(A)	2,120,823	-	$0	Indirect
Aug 14, 2026	ENHA Enhanced Group Inc.	Purchase(P)	150,000	$1.97	$295,620	Indirect
Jul 22, 2026	ENHA Enhanced Group Inc.	Award(A)	3,020,565	-	$0	Indirect
May 7, 2026	ENHA Enhanced Group Inc.	Award(A)	29,692,247	-	$0	Indirect
May 7, 2026	ENHA Enhanced Group Inc.	Award(A)	258,837,933	-	$0	Indirect
Sep 30, 2025	ATAI ATAI Life Sciences N.V.	Conversion(C)	2,367,200	-	-	Indirect
Aug 14, 2025	ATAI ATAI Life Sciences N.V.	Purchase(P)	8,675,799	$2.19	$19,000,000	Indirect
Mar 24, 2025	ATAI ATAI Life Sciences N.V.	Purchase(P)	1,800,000	$1.40	$2,520,000	Indirect
Feb 14, 2025	ATAI ATAI Life Sciences N.V.	Purchase(P)	10,835,718	$2.10	$22,755,008	Indirect
Oct 4, 2024	BNOX BIONOMICS LTD/ADR	Sale(S)	557	$0.28	$156	Indirect
Oct 3, 2024	BNOX BIONOMICS LTD/ADR	Sale(S)	180,707	$0.29	$52,405	Indirect
Oct 2, 2024	BNOX BIONOMICS LTD/ADR	Sale(S)	90,806	$0.33	$29,966	Indirect

1-22 of 22 transactions

About Apeiron Investment Group Ltd.

Apeiron Investment Group Ltd. (SEC CIK 0001845711) files insider reports with the SEC as Director of Enhanced Group Inc. (ENHA), 10% Owner of ATAI Life Sciences N.V. (ATAI) and 10% Owner of BIONOMICS LTD/ADR (BNOX).

Signal8 holds 15 ownership filings by Apeiron Investment Group Ltd. (2 Form 3, 13 Form 4), filed between Oct 7, 2024 and Sep 21, 2026. Those filings report 22 transactions, from Oct 2, 2024 to Sep 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Apeiron Investment Group Ltd.'s filings is in BIRKIRKARA.

Recent filings by Apeiron Investment Group Ltd.

Sep 17, 2026: Open-market purchase of ENHA shares (Form 4, code P).
Sep 9, 2026: Open-market purchase of ENHA shares (Form 4, code P).
Sep 8, 2026: Open-market purchase of ENHA shares (Form 4, code P).
Sep 4, 2026: Open-market purchase of ENHA shares (Form 4, code P).
Sep 3, 2026: Open-market purchase of ENHA shares (Form 4, code P).

Other insiders filing for Enhanced Group Inc. (ENHA)

Eisenberg Anthony D., Director
Han Juliette, Director
Sepso Michael, Director
Simpson James Gaskill, Director
Martin Maximilian, Chief Executive Officer
ASPAC IV (Holdings) Corp., 10% Owner

How to read Form 4 transaction codes